1. Home
  2. SAVA vs ALGT Comparison

SAVA vs ALGT Comparison

Compare SAVA & ALGT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SAVA
  • ALGT
  • Stock Information
  • Founded
  • SAVA 1998
  • ALGT 1997
  • Country
  • SAVA United States
  • ALGT United States
  • Employees
  • SAVA N/A
  • ALGT N/A
  • Industry
  • SAVA Biotechnology: Pharmaceutical Preparations
  • ALGT Air Freight/Delivery Services
  • Sector
  • SAVA Health Care
  • ALGT Consumer Discretionary
  • Exchange
  • SAVA Nasdaq
  • ALGT Nasdaq
  • Market Cap
  • SAVA 1.3B
  • ALGT 1.3B
  • IPO Year
  • SAVA N/A
  • ALGT 2006
  • Fundamental
  • Price
  • SAVA $26.91
  • ALGT $77.69
  • Analyst Decision
  • SAVA Strong Buy
  • ALGT Hold
  • Analyst Count
  • SAVA 3
  • ALGT 9
  • Target Price
  • SAVA $111.50
  • ALGT $69.22
  • AVG Volume (30 Days)
  • SAVA 1.3M
  • ALGT 472.1K
  • Earning Date
  • SAVA 11-07-2024
  • ALGT 10-30-2024
  • Dividend Yield
  • SAVA N/A
  • ALGT 3.09%
  • EPS Growth
  • SAVA N/A
  • ALGT N/A
  • EPS
  • SAVA N/A
  • ALGT N/A
  • Revenue
  • SAVA N/A
  • ALGT $2,495,886,000.00
  • Revenue This Year
  • SAVA N/A
  • ALGT $1.56
  • Revenue Next Year
  • SAVA N/A
  • ALGT $11.22
  • P/E Ratio
  • SAVA N/A
  • ALGT N/A
  • Revenue Growth
  • SAVA N/A
  • ALGT N/A
  • 52 Week Low
  • SAVA $8.79
  • ALGT $36.09
  • 52 Week High
  • SAVA $42.20
  • ALGT $85.91
  • Technical
  • Relative Strength Index (RSI)
  • SAVA 51.05
  • ALGT 74.30
  • Support Level
  • SAVA $25.00
  • ALGT $72.56
  • Resistance Level
  • SAVA $28.18
  • ALGT $75.87
  • Average True Range (ATR)
  • SAVA 1.81
  • ALGT 4.04
  • MACD
  • SAVA 0.07
  • ALGT 0.56
  • Stochastic Oscillator
  • SAVA 62.39
  • ALGT 97.86

About SAVA Cassava Sciences Inc.

Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.

About ALGT Allegiant Travel Company

Allegiant Travel Co provides travel services in the United States. It sells air transportation on a stand-alone basis or bundled with air-related and third-party services and products. Customers may also purchase fixed-fee flying arrangements to receive charter service on a year-round and ad hoc basis. Additionally, customers may purchase hotel rooms, ground transportation, and other attractions (for example, entertainment show tickets) to accommodate a trip. The company's operating segment includes Airline, Sunseeker Resort, and other non-airlines. Customers purchase travel tickets at airport ticket counters, online, or through its telephone reservation center.

Share on Social Networks: